1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate.

Ramnauth J, Renton P, Dove P, Annedi SC, Speed J, Silverman S, Mladenova G, Maddaford SP, Zinghini S, Rakhit S, Andrews J, Lee DK, Zhang D, Porreca F

Open source

DOI
10.1021/jm3000449
Published
2012 Mar 22
Container
Journal of medicinal chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/jm3000449,
  title = {1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate.},
  author = {Ramnauth J and Renton P and Dove P and Annedi SC and Speed J and Silverman S and Mladenova G and Maddaford SP and Zinghini S and Rakhit S and Andrews J and Lee DK and Zhang D and Porreca F},
  year = {2012},
  journal = {Journal of medicinal chemistry},
  doi = {10.1021/jm3000449},
  url = {https://doi.org/10.1021/jm3000449}
}

RIS

TY  - JOUR
TI  - 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate.
AU  - Ramnauth J
AU  - Renton P
AU  - Dove P
AU  - Annedi SC
AU  - Speed J
AU  - Silverman S
AU  - Mladenova G
AU  - Maddaford SP
AU  - Zinghini S
AU  - Rakhit S
AU  - Andrews J
AU  - Lee DK
AU  - Zhang D
AU  - Porreca F
PY  - 2012
JO  - Journal of medicinal chemistry
DO  - 10.1021/jm3000449
UR  - https://doi.org/10.1021/jm3000449
ER  - 

APA

J, R., P, R., P, D., SC, A., J, S., S, S., G, M., SP, M., S, Z., S, R., J, A., DK, L., D, Z., & F, P. (2012). 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate.. Journal of medicinal chemistry. https://doi.org/10.1021/jm3000449

Source records